DICEMBRINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.192
EU - Europa 3.787
AS - Asia 2.495
SA - Sud America 526
AF - Africa 60
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.148
RU - Federazione Russa 1.567
PL - Polonia 942
SG - Singapore 696
CN - Cina 544
HK - Hong Kong 501
BR - Brasile 418
IE - Irlanda 349
IT - Italia 336
KR - Corea 239
VN - Vietnam 216
SE - Svezia 190
DE - Germania 100
FI - Finlandia 98
IN - India 79
JO - Giordania 52
AU - Australia 49
AR - Argentina 48
GB - Regno Unito 46
FR - Francia 45
ID - Indonesia 40
TR - Turchia 32
UA - Ucraina 30
CI - Costa d'Avorio 26
CH - Svizzera 25
EC - Ecuador 24
BD - Bangladesh 18
JP - Giappone 18
CA - Canada 17
MX - Messico 17
NL - Olanda 17
ES - Italia 13
IQ - Iraq 13
ZA - Sudafrica 13
CO - Colombia 12
MA - Marocco 8
PK - Pakistan 8
EG - Egitto 7
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
AL - Albania 5
CL - Cile 5
LT - Lituania 5
AZ - Azerbaigian 4
LV - Lettonia 4
MD - Moldavia 4
PT - Portogallo 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
BE - Belgio 2
BH - Bahrain 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
PA - Panama 2
PH - Filippine 2
PR - Porto Rico 2
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.112
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.422
Warsaw 942
Fairfield 682
Ashburn 544
Singapore 482
Hong Kong 427
Dublin 349
Woodbridge 312
Seattle 298
Chandler 277
Cambridge 273
Houston 254
Seoul 239
Wilmington 227
Beijing 185
Lawrence 138
Altamura 135
Princeton 107
Ann Arbor 103
Hefei 103
Moscow 103
Florence 90
Los Angeles 87
Ho Chi Minh City 84
Buffalo 75
Dallas 59
Boston 56
Mumbai 52
Melbourne 49
Kent 47
Medford 47
San Diego 44
Hanoi 41
New York 41
Boardman 34
Munich 34
Paris 32
São Paulo 31
Clifton 28
Shanghai 28
Abidjan 26
Falls Church 25
Helsinki 24
Jacksonville 24
Jakarta 24
Bern 21
Dong Ket 18
Turku 18
Andover 16
Rio de Janeiro 16
Tokyo 16
Redondo Beach 14
Guangzhou 13
Izmir 12
Falkenstein 11
Quito 11
Norwalk 10
Hillsboro 9
Phoenix 9
Porto Alegre 9
Ankara 8
Hải Dương 8
London 8
Montreal 8
Redwood City 8
Bengaluru 7
Chicago 7
Curitiba 7
Fortaleza 7
Frankfurt am Main 7
Guarulhos 7
Manaus 7
The Dalles 7
Toronto 7
Agawam 6
Bogotá 6
Johannesburg 6
Redmond 6
Rome 6
Tashkent 6
Thái Bình 6
Tianjin 6
Yubileyny 6
Amman 5
Baghdad 5
Biên Hòa 5
Chennai 5
Denver 5
Feira de Santana 5
Lappeenranta 5
Mexico City 5
Milan 5
Orangeburg 5
Perugia 5
Salt Lake City 5
Thái Nguyên 5
Amsterdam 4
Baku 4
Bari 4
Bauru 4
Totale 9.125
Salva come PNG Salva come JPEG
Nome #
Adipokines as possible new predictors of cardiovascular diseases: a case control study. 322
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 302
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 293
Psychopathology and continuous subcutaneous insulin infusion in type 1 diabetes 276
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. 253
“Persistente secrezione di Exendin-4, un agonista recettoriale del Glucagon-like peptide-1, mediante terapia genica mediata da Adeno-associated Viruses, su ghiandole salivari di roditori in due differenti modelli di obesità/diabete tipo 2” 253
The therapy of insulin resistance in other diseases besides type 2 diabetes. 211
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 199
Cardiovascular effects of basal insulins 193
Effect of dipeptidyl-peptidase 4 inhibitors on circulating oxidative stress biomarkers in patients with type 2 diabetes mellitus 192
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 191
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 185
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 184
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 178
Hormonal signaling in biology and medicine 176
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 163
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. 158
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 157
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 155
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 154
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 147
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 147
Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. 144
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 143
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies 142
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 142
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 141
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 141
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 140
A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes 139
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 139
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 139
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 138
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. 137
Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis 135
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 135
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 134
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 133
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 131
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 131
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 131
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists 131
Drugs for type 2 diabetes: Role in the regulation of bone metabolism 129
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 128
Deprescription in elderly patients with type 2 diabetes mellitus 128
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies 127
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes 127
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 127
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 127
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 125
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 125
Bone: incretin hormones perceiver or receiver? 124
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 124
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 123
Vitamin D therapy in adults with diabetes mellitus. 122
Measurement of body composition as a surrogate evaluation of energy balance in obese patients. 121
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 120
Orlistat and sibutramine beyond weight loss 119
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies 118
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. 118
The impossible return to the Garden of Eden: The ORIGIN trial and the original sin of early insulin treatment of type 2 diabetes 118
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 116
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 114
Predictors of efficacy of Sodium-GLucose Transporter-2 inhibitors and Glucagon-Like Peptide 1 receptor agonists: A retrospective cohort study 113
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials 113
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 113
Plasma adiponectin and hyperglycaemia in diabetic patients 112
Correction to: Glucose control in diabetes during home confinement for the first pandemic wave of COVID‑19: a meta‑analysis of observational studies (Acta Diabetologica, (2021), 58, 12, (1603-1611), 10.1007/s00592-021-01754-2) 112
Cigarette Smoking as a Predictor of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Genital Infections: A Retrospective Cohort Study 110
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials 109
Incretin-based therapies and cardiovascular risk 106
Lipids seasonal variability in type 2 diabetes. 105
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 105
Is glucose control important for prevention of cardiovascular disease in diabetes? 104
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 104
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials 104
Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue? 102
Use of ancient grains for the management of diabetes mellitus: A systematic review and meta-analysis 102
Inflammation markers and metabolic characteristic of subjects with one-hour plasma glucose levels 101
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials 101
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. 101
Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support 99
Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials 97
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 95
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials 95
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 93
Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials (Acta Diabetologica, (2017), 54, 1, (19-36), 10.1007/s00592-016-0892-7) 92
Is there a practical way of predicting therapeutic success in type 2 diabetes on the basis of psychological features? Development and validation of the Psychological Predictors of Therapeutic success in Diabetes (PPTD) questionnaire 91
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials 91
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention 87
Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion 86
Diabetes as a risk factor for invasive meningococcal disease. A meta-analysis of observational studies 85
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. 82
Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. 81
Le modificazioni dello stile di vita: curarsi o essere curato? 78
Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials 76
Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet mice 69
EFFECTS OF ANTIHYPERTENSIVE TREATMENTS ON INCIDENCE OF DIABETES: A CASE-CONTROL STUDY. 68
Totale 13.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021539 0 0 0 0 0 100 73 55 91 90 68 62
2021/2022549 14 39 54 23 16 32 27 36 24 40 61 183
2022/20231.524 179 354 58 86 62 258 203 64 159 8 50 43
2023/2024569 24 61 98 28 34 48 19 103 13 55 66 20
2024/20254.264 147 425 340 618 1.161 622 92 278 211 110 130 130
2025/20262.703 489 697 421 466 619 11 0 0 0 0 0 0
Totale 13.197